Hemophagocytic Lymphohistiocytosis Recruiting Phase 2 Trials for Fludarabine (DB01073)

Also known as: Hemophagocytic Lymphohistiocytosis (HLH) / Haemophagocytic Lymphohistiocytosis / Hemophagocytic Lymphohistiocytoses / Hemophagocytic Lymphohisticytosis / Hemophagocytic lymphohistiocytosis (disorder) / Lymphohistiocytosis, Hemophagocytic / Primary hemophagocytic lymphohistiocytosis / Primary haemophagocytic lymphohistiocytosis / Familial hemophagocytic lymphohistiocytosis (disorder) / Familial Hemophagocytic Lymphocytosis / Familial haemophagocytic lymphohistiocytosis / Familial hemophagocytic lymphohistiocytosis

IndicationStatusPhase
DBCOND0029166 (Hemophagocytic Lymphohistiocytosis)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01821781
Immune Disorder HSCT ProtocolTreatment